ORAMED PHARMACEUTICALS INC. (ORMP)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $611k
- Jul 1 · No plan
- Form 4 sales
- 21
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualAug 9 2021
Sold 220,000 shares at $20.11 ($4.4M)
Kidron Nadav, President and CEO
Sold 25.3% of holdings ($17.5M position)648,573 shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualSep 16 +38 days
Sold 21,100 shares at $20.99 ($443k)
Rakin Kevin, Director
Sold 27% of holdings ($1.6M position)57,004 shares leftFirst sale on recordFiling
- 3 Form 4 saleUnusualNov 1 +46 days
Sold 3,000 shares at $25.60 ($77k)
Mayer Arie, Director
Sold 100% of holdings ($77k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 salePlan not statedMar 21 +140 days
Sold 10,000 shares at $9.41 ($94k)
Rakin Kevin, Director
Sold 17.6% of holdings ($533k position)46,661 shares leftFiling
- 5 Form 4 salePlan not statedJan 3 +288 days
Sold 13,325 shares at $12.55 ($167k)
Rabinowitz Michael, Chief Commercial Officer
Sold 9.6% of holdings ($1.7M position)126,143 shares leftFirst sale on recordFiling
- 6 Form 4 saleUnusualMar 14 +70 days
Sold 100,000 shares at $2.01 ($201k)
Kidron Miriam, Chief Scientific Officer
Sold 33.1% of holdings ($606k position)201,666 shares leftFirst sale on recordFiling
- 7 Form 4 saleNo planJul 1 +1205 days
Sold 73,360 shares at $4.51 ($331k)
Gabay Avraham, Chief Financial Officer
No 10b5-1 planSold 9.8% of holdings ($3.4M position)671,785 shares leftFirst sale on recordFiling
- 8 Form 4 saleNo planJul 1 same day
Sold 137,000 shares at $4.46 ($611k)
Hexter Joshua, COO & CBO
No 10b5-1 planSold 11.8% of holdings ($5.2M position)1M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (21)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Hexter Joshua | COO & CBO | Form 4 sale | 137,000 | $611k | 11.8% | No plan | SEC |
| Jul 1, 2026 | Gabay Avraham | Chief Financial Officer | Form 4 sale | 73,360 | $331k | 9.8% | No plan | SEC |
| Mar 14, 2023 | Kidron Miriam | Chief Scientific Officer | Form 4 sale | 100,000 | $201k | 33.1% | Unusual | SEC |
| Jan 3, 2023 | Rabinowitz Michael | Chief Commercial Officer | Form 4 sale | 13,325 | $167k | 9.6% | Plan not stated | SEC |
| Mar 21, 2022 | Rakin Kevin | Director | Form 4 sale | 10,000 | $94k | 17.6% | Plan not stated | SEC |
| Nov 1, 2021 | Mayer Arie | Director | Form 4 sale | 3,000 | $77k | 100.0% | Unusual | SEC |
| Sep 16, 2021 | Rakin Kevin | Director | Form 4 sale | 21,100 | $443k | 27.0% | Unusual | SEC |
| Aug 9, 2021 | Kidron Nadav | President and CEO | Form 4 sale | 220,000 | $4.4M | 25.3% | Unusual | SEC |
| Jul 10, 2018 | Kidron Nadav | President and CEO | Form 4 sale | 61 | $365 | 0.0% | Plan not stated | SEC |
| Aug 2, 2017 | Kidron Miriam | Chief Scientific Officer | Form 4 sale | 89,636 | $762k | 54.4% | Unusual | SEC |
| Apr 19, 2017 | Kidron Miriam | Chief Scientific Officer | Form 4 sale | 52,814 | $334k | 37.1% | Unusual | SEC |
| Mar 10, 2016 | Jacob Harold | Director | Form 4 sale | 8,500 | $55k | 34.1% | Unusual | SEC |
| Dec 30, 2015 | Kidron Miriam | Chief Technology Officer | Form 4 sale | 50,000 | $445k | 26.0% | Unusual | SEC |
| Dec 9, 2015 | Berelowitz Michael | Director | Form 4 sale | 700 | $7k | 3.0% | Plan not stated | SEC |
| Dec 8, 2015 | Berelowitz Michael | Director | Form 4 sale | 1,300 | $11k | 5.2% | Plan not stated | SEC |
| Sep 11, 2014 | Kidron Miriam | Chief Technology Officer | Form 4 sale | 31,699 | $267k | 23.6% | Plan not stated | SEC |
| Sep 4, 2014 | Kidron Miriam | Chief Technology Officer | Form 4 sale | 8,301 | $78k | 5.8% | Plan not stated | SEC |
| Apr 1, 2014 | Kidron Miriam | Chief Technology Officer | Form 4 sale | 137,300 | $1.7M | 100.0% | Unusual | SEC |
| Mar 31, 2014 | Berelowitz Michael | Director | Form 4 sale | 9,434 | $99k | 100.0% | Unusual | SEC |
| Dec 30, 2013 | Jacob Harold | Director | Form 4 sale | 834 | $13k | 100.0% | Unusual | SEC |
| Sep 27, 2011 | Bronfeld Zeev | 10% owner | Form 4 sale | 350,000 | $98k | 5.7% | Plan not stated | SEC |